Renal Cell Carcinoma: Clinical Features and Management
In 1999 it was estimated that renal cell carcinoma (RCC) would account for 29,990 new cancer cases diagnosed in the United States (61% in men and 39% in women), and lead to 11,600 deaths. RCC accounts for 2–3% of all malignancies in adults and causes 2.3% of all cancer deaths in the United States annually (1 ). Approx 4% of all RCC cases are bilateral at some point in the life of the patient. Data from over 10,000 cases of renal cancer entered in the Connecticut Tumor Registry suggests an increase in the incidence of renal cancer from 1935–1989; in women the incidence increased from 0.7 to 4.2 in 100,000, and in men from 1.6 to 9.6 in 100,000 (2 ). Factors implicated in the development of RCC include cigarette smoking, exposure to petroleum products, obesity, diuretic use, cadmium exposure, and ionizing radiation (3 –9 ).
- Establishment and Culture of LeukemiaLymphoma Cell Lines
- Strategies for Improving the Anti-Neoplastic Activity of TNF by Tumor Targeting
- Molecular Basis of Histone Deacetylase Inhibitors as New Drugs for the Treatment of Inflammatory Diseases and Cancer
- Tissue Microarrays
- In Vitro Invasion Assays
- Quantitation of RNA by Ribonuclease Protection Assay
- Use of Minicircle Plasmids for Gene Therapy
- Altered Surface Markers in Lung Cancer: Lack of Cell-Surface Fas/APO-1 Expression in Pulmonary Adenocarcinoma May Allow Escape f
- Manipulating Expression of Endogenous Oncogenic Proteins Using an Antisense Oligonucleotide Approach in Prostate Cancer Cells
- Construction and Characterization of Minibodies for Imaging and Therapy of Colorectal Carcinomas